SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Financial burden in adults with chronic liver disease: A scoping review
16 references·0 citing·35 second hop
Financial burden in adults with chronic liver disease: A scoping review (2022)Financial burden in adults with chronic l…A Policy Prescription for Reducing Health Disparities—Achieving Pharmacoequity (2021)A Policy Prescription for Red…Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions (2020)Financial Toxicity in Atheros…Assessment of Parking Fees at National Cancer Institute–Designated Cancer Treatment Centers (2020)Assessment of Parking Fees at…A Pilot Study of a Comprehensive Financial Navigation Program in Patients With Cancer and Caregivers (2020)A Pilot Study of a Comprehens…Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications (2019)Methods for measuring financi…Rayyan—a web and mobile app for systematic reviews (2016)Rayyan—a web and mobile app f…Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer (2016)Out-of-Pocket Spending and Fi…Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016)Measuring financial toxicity …Financial Hardships Experienced by Cancer Survivors: A Systematic Review (2016)Financial Hardships Experienc…Direct and Indirect Economic Burden of Chronic Liver Disease in the United States (2016)Direct and Indirect Economic …A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay (2016)A Systematic Review of Financ…The development of a financial toxicity patient‐reported outcome in cancer: The COST measure (2014)The development of a financia…The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)The Financial Toxicity of Can…Financial toxicity, Part I: a new name for a growing problem. (2013)Financial toxicity, Part I: a…Scoping studies: towards a methodological framework (2005)Scoping studies: towards a me…Household catastrophic health expenditure: a multicountry analysis (2003)Household catastrophic health…An Index of Factorial Simplicity (1974)Constructing validity: Basic issues in objective scale development. (1995)Methods for the Economic Evaluation of Health Care Programmes (2005)Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors (2015)Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes (2019)Economics and Consumer Behavior (1980)Protecting Households From Catastrophic Health Spending (2007)Progress on catastrophic health spending in 133 countries: a retrospective observational study (2017)Catastrophic health spending in Europe: equity and policy implications of different calculation methods (2018)Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)Long-Term Financial Burden of Breast Cancer: Experiences of a Diverse Cohort of Survivors Identified Through Population-Based Registries (2014)Patient-Oncologist Cost Communication, Financial Distress, and Medication Adherence (2014)Financial toxicity in cancer care: origins, impact, and solutions (2021)A new scale of social desirability independent of psychopathology. (1960)Health Measurement Scales: A Practical Guide to Their Development and Use (1989)The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study (2010)The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment (2018)Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies (2019)Stress: Appraisal and Coping (2013)Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer (2016)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration (2009)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis (2013)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Digital Mental Health Interventions for Depression, Anxiety, and Enhancement of Psychological Well-Being Among College Students: Systematic Review (2019)An open source machine learning framework for efficient and transparent systematic reviews (2021)Barriers to and Facilitators of User Engagement With Digital Mental Health Interventions: Systematic Review (2021)Scoping studies: advancing the methodology (2010)PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach (2018)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions (2020)Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis (2022)
this work references cited by second hop

References

  • 2005Scoping studies: towards a methodological framework36,603 cited
  • 2016Rayyan—a web and mobile app for systematic reviews25,980 cited
  • 2003Household catastrophic health expenditure: a multicountry analysis2,316 cited
  • 2013The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience1,133 cited
  • 2016Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)928 cited
  • 2016Financial Hardships Experienced by Cancer Survivors: A Systematic Review861 cited
  • 2014The development of a financial toxicity patient‐reported outcome in cancer: The COST measure692 cited
  • 2013Financial toxicity, Part I: a new name for a growing problem.502 cited
  • 2016A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay480 cited
  • 2019Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications274 cited
  • 2016Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer220 cited
  • 2021A Policy Prescription for Reducing Health Disparities—Achieving Pharmacoequity183 cited
  • 2016Direct and Indirect Economic Burden of Chronic Liver Disease in the United States179 cited
  • 2020

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions
146 cited
  • 2020A Pilot Study of a Comprehensive Financial Navigation Program in Patients With Cancer and Caregivers88 cited
  • 2020Assessment of Parking Fees at National Cancer Institute–Designated Cancer Treatment Centers84 cited
  • Cited by

    No citing works inside the corpus for this window.